Viewing Study NCT06314828

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:11 AM
Ignite Modification Date: 2026-06-04 @ 5:48 PM
Study NCT ID: NCT06314828
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-18
First Post: 2024-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHL
Sponsor: Guangdong Ruishun Biotech Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Non-Hodgkin's Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None off-the-shelf cell product View
None CAR-DNT View
None Cell Therapy View
None B-NHL View